| Literature DB >> 25579084 |
Harsha Karur Rajasimha1, Prasannakumar Basayya Shirol1, Preveen Ramamoorthy1, Madhuri Hegde1, Sangeeta Barde1, Vijay Chandru1, M E Ravinandan1, Ramani Ramchandran2, Kasturi Haldar3, Jimmy C Lin4, Imran A Babar4, Katta M Girisha5, Sudha Srinivasan6, Duraiswamy Navaneetham7, Rajani Battu8, Rajashree Devarakonda9, Usha Kini10, Kinnimulki Vijayachandra11, Ishwar C Verma12.
Abstract
In order to address the unmet needs and create opportunities that benefit patients with rare disease in India, a group of volunteers created a not-for-profit organization named Organization for Rare Diseases India (ORDI; www.ordindia.org). ORDI plans to represent the collective voice and advocate the needs of patients with rare diseases and other stakeholders in India. The ORDI team members come from diverse backgrounds such as genetics, molecular diagnostics, drug development, bioinformatics, communications, information technology, patient advocacy and public service. ORDI builds on the lessons learned from numerous similar organizations in the USA, European Union and disease-specific rare disease foundations in India. In this review, we provide a background on the landscape of rare diseases and the organizations that are active in this area globally and in India. We discuss the unique challenges in tackling rare diseases in India, and highlight the unmet needs of the key stakeholders of rare diseases. Finally, we define the vision, mission, goals and objectives of ORDI, identify the key developments in the health care context in India and welcome community feedback and comments on our approach.Entities:
Mesh:
Year: 2014 PMID: 25579084 PMCID: PMC7044965 DOI: 10.1017/S0016672314000111
Source DB: PubMed Journal: Genet Res (Camb) ISSN: 0016-6723 Impact factor: 1.588